BDBM50099728 4-{2-[2-(2-Acetylamino-3-hydroxy-butyrylamino)-propionylamino]-3-hydroxy-butyrylamino}-4-[({3-carbamoyl-1-[1-carboxy-2-(9,10-dioxo-9,10-dihydro-phenanthren-2-ylcarbamoyl)-ethylcarbamoyl]-propylcarbamoyl}-methyl)-carbamoyl]-butyric acid::CHEMBL299586

SMILES CC(O)C(NC(C)=O)C(=O)NC(C)C(=O)NC(C(C)O)C(=O)NC(CCC(O)=O)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)N[C@@H](CC(=O)Nc1ccc2-c3ccccc3C(=O)C(=O)c2c1)C(O)=O

InChI Key InChIKey=RPSLNWOXIGGTPR-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50099728   

TargetReceptor-type tyrosine-protein phosphatase C(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099728(4-{2-[2-(2-Acetylamino-3-hydroxy-butyrylamino)-pro...)
Affinity DataIC50: 1.80E+3nMAssay Description:In vitro inhibitory activity against the cytosolic portion of CD45 protein-tyrosine phosphatase using pNPP as the substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed